Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-11 Sale | 2026-02-13 8:00 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 20,000 | $63.35 | $1,266,953 | 1,172,987 (Direct) | View |
| 2026-02-04 Sale | 2026-02-04 8:02 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 5,500 | $65.79 | $361,860 | 346,563 (Direct) | View |
| 2026-02-02 Sale | 2026-02-04 8:01 pm | Apogee Therapeutics Inc. | APGE | Henderson Jane Chief Financial Officer | 2,000 | $65.81 | $131,630 | 183,371 (Direct) | View |
| 2026-01-22 Sale | 2026-01-22 8:07 pm | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 1,750,000 | $76.3 | $133,525,000 | 7,144,300 (Indirect) | View |
| 2026-01-14 Sale | 2026-01-16 8:00 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 20,000 | $81.11 | $1,622,159 | 1,192,987 (Direct) | View |
| 2026-01-07 Sale | 2026-01-09 8:00 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 18,700 | $77.84 | $1,455,613 | 352,063 (Direct) | View |
| 2026-01-02 Sale | 2026-01-06 8:00 pm | Apogee Therapeutics Inc. | APGE | Henderson Jane Chief Financial Officer | 8,000 | $76.14 | $609,146 | 269,061 (Direct) | View |
| 2025-12-19 Sale | 2025-12-23 8:00 pm | Apogee Therapeutics Inc. | APGE | Henderson Jane Chief Financial Officer | 1,500 | $80 | $120,000 | 193,371 (Direct) | View |
| 2025-12-10 Sale | 2025-12-12 8:00 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 20,000 | $75.38 | $1,507,657 | 1,212,987 (Direct) | View |
| 2025-12-04 Sale | 2025-12-05 8:03 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 10,900 | $75 | $817,500 | 271,108 (Direct) | View |
| 2025-12-04 Sale | 2025-12-05 8:02 pm | Apogee Therapeutics Inc. | APGE | Henderson Jane Chief Financial Officer | 1,500 | $75 | $112,500 | 194,871 (Direct) | View |
| 2025-12-04 Sale | 2025-12-05 8:00 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 40,000 | $75.01 | $3,000,400 | 1,232,987 (Direct) | View |
| 2025-11-25 Sale | 2025-11-28 8:00 pm | Apogee Therapeutics Inc. | APGE | Henderson Jane Chief Financial Officer | 1,500 | $70 | $105,000 | 196,371 (Direct) | View |
| 2025-11-14 Sale | 2025-11-14 8:00 pm | Apogee Therapeutics Inc. | APGE | Henderson Jane Chief Financial Officer | 2,000 | $65 | $130,000 | 197,871 (Direct) | View |
| 2025-11-11 Sale | 2025-11-13 8:37 pm | Apogee Therapeutics Inc. | APGE | Henderson Jane Chief Financial Officer | 1,000 | $60 | $60,000 | 199,871 (Direct) | View |
| 2025-11-13 Sale | 2025-11-13 8:24 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 20,000 | $63.01 | $1,260,236 | 1,272,987 (Direct) | View |
| 2025-11-05 Sale | 2025-11-07 8:00 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 10,785 | $55.07 | $593,903 | 435,573 (Direct) | View |
| 2025-10-01 Sale | 2025-10-03 8:00 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 5,110 | $39.8 | $203,378 | 446,358 (Direct) | View |
| 2025-09-03 Sale | 2025-09-05 8:00 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 2,725 | $37.87 | $103,198 | 233,548 (Direct) | View |
| 2025-08-06 Sale | 2025-08-08 8:00 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 2,725 | $37.78 | $102,951 | 236,273 (Direct) | View |
| 2025-07-02 Sale | 2025-07-03 8:00 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 10,090 | $45.09 | $454,954 | 403,008 (Direct) | View |
| 2025-06-04 Sale | 2025-06-06 8:01 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 2,725 | $36.96 | $100,716 | 241,723 (Direct) | View |
| 2025-05-07 Sale | 2025-05-09 8:01 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 2,725 | $35.75 | $97,419 | 244,448 (Direct) | View |
| 2025-04-02 Sale | 2025-04-04 8:01 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 3,860 | $36.22 | $139,801 | 247,173 (Direct) | View |
| 2025-03-05 Sale | 2025-03-07 8:02 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 1,590 | $30.48 | $48,463 | 251,033 (Direct) | View |
| 2025-03-05 Sale | 2025-03-07 8:01 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 10,000 | $30.15 | $301,511 | 1,292,987 (Direct) | View |
| 2025-02-05 Sale | 2025-02-07 8:02 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 3,520 | $40.69 | $143,229 | 423,998 (Direct) | View |
| 2025-02-05 Sale | 2025-02-07 8:01 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 15,000 | $40.58 | $608,700 | 1,302,987 (Direct) | View |
| 2025-01-08 Sale | 2025-01-10 8:00 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 15,000 | $48.85 | $732,693 | 1,309,487 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-04 Exercise | 2026-02-04 8:02 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 4,125 | $22.86 | 346,563 (Direct) | View |
| 2026-02-04 Exercise | 2026-02-04 8:02 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 4,125 | $0 | 346,563 (Direct) | View |
| 2026-01-07 Exercise | 2026-01-09 8:00 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 14,025 | $22.86 | 352,063 (Direct) | View |
| 2026-01-07 Exercise | 2026-01-09 8:00 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 14,025 | $0 | 352,063 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 8:03 pm | N/A 2036-01-02 | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 83,690 | $0 | 83,690 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 8:01 pm | N/A 2036-01-02 | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 253,016 | $0 | 253,016 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 8:00 pm | N/A 2036-01-02 | Apogee Therapeutics Inc. | APGE | Henderson Jane Chief Financial Officer | 83,690 | $0 | 269,061 (Direct) | View |
| 2025-11-05 Exercise | 2025-11-07 8:00 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 8,060 | $22.86 | 435,573 (Direct) | View |
| 2025-11-05 Exercise | 2025-11-07 8:00 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 8,060 | $0 | 435,573 (Direct) | View |
| 2025-10-01 Exercise | 2025-10-03 8:00 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 2,385 | $22.86 | 446,358 (Direct) | View |
| 2025-10-01 Exercise | 2025-10-03 8:00 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 2,385 | $0 | 446,358 (Direct) | View |
| 2025-07-02 Exercise | 2025-07-03 8:00 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 7,365 | $22.86 | 403,008 (Direct) | View |
| 2025-07-02 Exercise | 2025-07-03 8:00 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 7,365 | $0 | 403,008 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 8:06 pm | N/A 2035-06-17 | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director | 28,922 | $0 | 28,922 (Indirect) | View |
| 2025-06-17 Option Award | 2025-06-20 8:05 pm | N/A 2035-06-17 | Apogee Therapeutics Inc. | APGE | Shah Nimish P Director | 14,461 | $0 | 14,461 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 8:04 pm | N/A 2035-06-17 | Apogee Therapeutics Inc. | APGE | McKenna Mark C. Director | 14,461 | $0 | 14,461 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 8:03 pm | N/A 2035-06-17 | Apogee Therapeutics Inc. | APGE | JONES WILLIAM A JR Director | 14,461 | $0 | 14,461 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 8:02 pm | N/A 2035-06-17 | Apogee Therapeutics Inc. | APGE | Gottesdiener Andrew Director | 14,461 | $0 | 14,461 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 8:01 pm | N/A 2035-06-17 | Apogee Therapeutics Inc. | APGE | Fox Jennifer A. Director | 14,461 | $0 | 14,461 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 8:00 pm | N/A 2035-06-17 | Apogee Therapeutics Inc. | APGE | Bollinger Lisa Director | 14,461 | $0 | 14,461 (Direct) | View |
| 2025-02-05 Exercise | 2025-02-07 8:02 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 795 | $22.86 | 423,998 (Direct) | View |
| 2025-02-05 Exercise | 2025-02-07 8:02 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 795 | $0 | 423,998 (Direct) | View |
| 2025-01-31 Exercise | 2025-01-31 8:00 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 8,500 | $22.86 | 1,707,999 (Direct) | View |
| 2025-01-31 Exercise | 2025-01-31 8:00 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 8,500 | $0 | 1,707,999 (Direct) | View |